Fair Value of Financial Instruments - Narrative (Details) - USD ($)	12 Months Ended
Dec. 31, 2023	Dec. 31, 2022
Fair Value of Financial Instruments
Assets transfer from level 1 to level 2	$ 0	$ 0
Level 3 Asset transferred, net	0	0
Level 3 liabilities transferred, net	0	0
Change in fair value of contingent consideration		(3,342,515)
Change in fair value of contingent consideration	(100,000)	$ (100,000)
Held for sale \| Elusys Therapeutics business unit
Fair Value of Financial Instruments
Reclassification to held for sale	(4,600,000)
Change in fair value of consideration receivable	$ 1,700,000

Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.

No definition available.

Name:	nhwk_AssetsTransferFromLevel1ToLevel2TransfersAmount1
Namespace Prefix:	nhwk_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Change in fair value of consideration receivable.

+ References

No definition available.

+ Details

Name:	nhwk_ChangeInFairValueOfConsiderationReceivable
Namespace Prefix:	nhwk_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Change in fair value of contingent consideration.

+ References

No definition available.

+ Details

Name:	nhwk_ChangeInFairValueOfContingentConsideration
Namespace Prefix:	nhwk_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Change in fair value of contingent consideration related to contingent considerations.

+ References

No definition available.

+ Details

Name:	nhwk_ChangeInFairValueOfContingentConsiderationDiscontinuedOperations
Namespace Prefix:	nhwk_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of payment related to reclassification to held for sale.

+ References

No definition available.

+ Details

Name:	nhwk_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToHeldForSale
Namespace Prefix:	nhwk_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.

+ References

No definition available.

+ Details

Name:	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy.

+ References

No definition available.

+ Details

Name:	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=nhwk_ElusysTherapeuticsIncBusinessMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: